HemoCath Medical Ltd. is an Irish/US Digital Health & MedTech startup transforming heart failure (HF) care with the HemoDynamix™ AI Platform — a first-of-its-kind, scalable solution for real-time diagnosis, treatment, and monitoring of HF patients.

The platform combines the HemoCath™ pulmonary artery (PA) catheter with the HemoDynamix™ AI Cloud (B2B AIoT/SaaS) to translate continuous, accurate cardiovascular hemodynamic data into clear actionable insights. Clinicians get faster, AI-guided decisions — improving patient outcomes, shortening hospital stays, and lowering healthcare costs. 

Our leadership team has over 150 years of combined experience in medicine, engineering, commercialization and corporate finance, with a proven track record in successfully bringing innovations to market.

At HemoCath, we are dedicated to advancing healthcare with the next generation of pulmonary artery catheters. Our mission is to enhance patient outcomes through innovative, precise, and reliable hemodynamic monitoring solutions. We strive to empower healthcare professionals with cutting-edge medical technology that improves decision-making, optimizes treatment, and sets new standards in cardiovascular care.